Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

49 evidence items · page 1 / 2

81 %Recovery rates for proteins and nucleic acids were highest for the vaginal veil (81% and 91%).

Gaboncancer du col de l'utérus · sexually transmitted infectionspublished 2026Diagnostics (Basel, Switzerland)PubMeddocument of 8 observations

2.5 per_100000Le cancer du col de l'utérus se classe comme le quatrième cancer le plus fréquent chez les femmes à l'échelle mondiale, avec des taux d’incidence standardisés selon l’âge qui varient de 2,5 à 55,0 cas pour 100 000 femmes.

Gaboncancer du col de l'utérusobserved 2020HAL · Unilimdocument of 322 observations

4.23 per_100000En 2024, l’incidence brute du cancer du col de l’utérus au Gabon était de 4,23 pour 100 000 habitants.

Gaboncancer du col de l'utérusobserved 2024HAL · Unilimdocument of 322 observations

8.4 per_100000The cervical cancer mortality rate is 8.4 per 100 000 women in Gabon.

Gaboncancer du col de l'utéruspublished 2015BMC women's healthPubMeddocument of 12 observations

49 casesIn 2022, the Institut de Cancérologie d'Afrique (ICA) in Gabon recorded 49 cervical cancer cases.

Gaboncancer du col de l'utérusobserved 2022HAL · Unilimdocument of 45 observations

7.3 %HPV 70 was detected in 7.3% of cervical cancer samples from Gabonese women.

Gaboncancer du col de l'utérusobserved 2007–2013 and August 2013published 2016Infectious agents and cancerPubMeddocument of 10 observations

50,000 deathsCervical cancer causes 50,000 deaths yearly in sub-Saharan Africa.

Gaboncancer du col de l'utéruspublished 2017Expert review of anti-infective therapyPubMeddocument of 3 observations

49 casesIn 2022, the ICA in Gabon recorded 49 cervical cancer cases.

Gaboncancer du col de l'utérusobserved 2022HAL · Unilimdocument of 45 observations

7.69 odds_ratioAmong HIV-positive cervical cancer patients, tumors were undifferentiated (grade III) with an odds ratio of 7.69 (95% CI: 5.80–9.57).

Gaboncancer du col de l'utérus · VIH/sidaobserved January 2010 to April 2017published 2021Obstetrics and gynecology internationalPubMeddocument of 4 observations

58.3 %HPV 16 was detected in 58.3% of cervical cancer samples from Gabonese women.

Gaboncancer du col de l'utérusobserved 2007–2013 and August 2013published 2016Infectious agents and cancerPubMeddocument of 10 observations

594 per_100000In 2022, the combined prevalence of breast and cervical cancers in women in Gabon was 594 per 100,000 women.

Gaboncancer du col de l'utérus · cancer du seinobserved 2022HAL · Unilimdocument of 45 observations

13 patientsAll thirteen Gabonese women diagnosed with breast or cervical cancer reported depressive symptoms ranging from minimal to moderately severe according to the Patient Health Questionnaire-9 (PHQ-9).

Gaboncancer du col de l'utérus · cancer du seinobserved 2023published 2025PloS onePubMed

25 %HPV 33 was detected in 25.0% of cervical cancer samples from Gabonese women.

Gaboncancer du col de l'utérusobserved 2007–2013 and August 2013published 2016Infectious agents and cancerPubMeddocument of 10 observations

16.2 per_100000Au Gabon, la prévalence du cancer du col de l'utérus était de 16,2 pour 100 000 habitantes en 2022.

Gaboncancer du col de l'utérusobserved 2022HAL · Unilimdocument of 322 observations

22.7 per_100000En Gabon, l'incidence du cancer du col de l'utérus est de 22,7 pour 100 000.

Gaboncancer du col de l'utérusHAL · Unilimdocument of 322 observations

Cervical cancer stages ranged from FIGO I to FIGO III.

Gaboncancer du col de l'utérusHAL · Unilimdocument of 45 observations

96 samplesHPV DNA was detected in all 96 HPV β-globin-positive cervical cancer samples from Gabonese women.

Gaboncancer du col de l'utérusobserved 2007–2013 and August 2013published 2016Infectious agents and cancerPubMeddocument of 10 observations

75,000 casesCervical cancer causes more than 75,000 new cases yearly in sub-Saharan Africa.

Gaboncancer du col de l'utéruspublished 2017Expert review of anti-infective therapyPubMeddocument of 3 observations

91.6 %Of 452 women interviewed, 91.6% had heard about cervical cancer.

Gaboncancer du col de l'utéruspublished 2015BMC women's healthPubMeddocument of 12 observations

7.7 %Highly oncogenic human papillomavirus (HPV) infections are responsible for 7.7% of cancers in developing countries, mainly cervical cancer.

Gaboncancer du col de l'utérus · infection à HPVpublished 2017Medecine et sante tropicalesPubMeddocument of 3 observations

32 %Parmi les 50 patients participants à la phase 2, 32,0 % avaient un cancer du col de l’utérus.

Gaboncancer du col de l'utérusHAL · Unilimdocument of 322 observations

6 fold_higher_riskWomen living with human immunodeficiency virus (WLWH) have a six-fold higher risk of developing cervical cancer associated with high-risk human Papillomavirus (HR-HPV) than HIV-negative women.

Gaboncancer du col de l'utérus · high-risk human papillomavirus · VIH/sidapublished 2025Diseases (Basel, Switzerland)PubMeddocument of 12 observations

16.2 per_100000En 2022, l'incidence du cancer du col de l'utérus au Gabon était de 16,2 pour 100 000 femmes.

Gaboncancer du col de l'utérusobserved 2022HAL · Unilimdocument of 322 observations

3.5 per_100Le risque cumulé de développer un cancer du col de l'utérus est de 3,5 % à l'âge de 75 ans chez les femmes africaines.

Gaboncancer du col de l'utérusHAL · Unilimdocument of 322 observations

7.7 %Infections caused by high-risk human papillomavirus (HPV) are responsible for 7.7% of cancers in developing countries, mainly cervical cancer.

Gaboncancer du col de l'utérus · infection à HPVpublished 2017Expert review of anti-infective therapyPubMeddocument of 3 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.